C Watson Selected Research

C Watson Research Topics

Disease

7	Neoplasms (Cancer) 01/2022 - 12/2000
6	Epilepsy (Aura) 06/2001 - 01/2000
2	Heart Failure 04/2017 - 12/2014
2	Necrosis 10/2014 - 09/2005
2	Seizures (Absence Seizure) 11/2001 - 09/2000
2	Headache (Headaches) 03/2001 - 02/2000
2	Migraine Disorders (Migraine) 03/2001 - 02/2000
1	Bites and Stings (Sting) 01/2022
1	Thrombosis (Thrombus) 01/2021
1	Venous Thromboembolism 01/2021
1	Medically Unexplained Symptoms 01/2020
1	Hemorrhage 05/2018
1	Cholesteatoma 04/2018
1	Sepsis (Septicemia) 12/2017
1	Burns 12/2017
1	Asthma (Bronchial Asthma) 06/2016
1	Drug-Related Side Effects and Adverse Reactions 06/2016
1	Arthritis (Polyarthritis) 06/2016
1	Cardiotoxicity 04/2016
1	Breast Neoplasms (Breast Cancer) 04/2016
1	Left Ventricular Dysfunction 04/2016
1	Multiple Sclerosis 11/2014
1	Inflammation (Inflammations) 10/2014
1	Atopic Dermatitis (Atopic Eczema) 10/2014
1	Prostatic Neoplasms (Prostate Cancer) 08/2014
1	Bone Resorption 10/2011
1	Weight Gain 10/2011
1	Postoperative Pain 12/2009
1	Nausea 12/2009
1	Upper Extremity Deep Vein Thrombosis 12/2007
1	Thrombophilia 12/2007
1	Epistaxis (Nosebleed) 09/2005
1	Type 2 Diabetes Mellitus (MODY) 08/2005
1	Femoral Neck Fractures 04/2005
1	Meningioma (Meningiomas) 01/2005
1	Acoustic Neuroma (Acoustic Neurinoma) 01/2005
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2005
1	Intestinal Failure 06/2003
1	Partial Epilepsies (Epilepsy, Partial) 06/2001
1	Dysentery 03/2001
1	Bacillary Dysentery (Shigellosis) 03/2001

Drug/Important Bio-Agent (IBA)

5	Glucose (Dextrose)FDA LinkGeneric 06/2001 - 01/2000
3	Pharmaceutical PreparationsIBA 01/2022 - 08/2014
3	Flumazenil (Romazicon)FDA LinkGeneric 06/2001 - 01/2000
2	EnzymesIBA 06/2016 - 10/2014
2	CytokinesIBA 10/2014 - 12/2000
2	TabletsIBA 03/2001 - 02/2000
2	naratriptan FDA LinkGeneric 03/2001 - 02/2000
1	Messenger RNA (mRNA)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2022
1	BuffersIBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	emactuzumabIBA 01/2019
1	Factor VIII (Coagulation Factor VIII)IBA 05/2018
1	bis(agmatine)oxalamide (Plt-I)IBA 12/2017
1	Unithiol (DMPS)IBA 04/2017
1	CytochromesIBA 06/2016
1	dibenzyl trisulfideIBA 06/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2016
1	Natriuretic PeptidesIBA 04/2016
1	Natalizumab (Tysabri)FDA Link 11/2014
1	Filaggrin ProteinsIBA 10/2014
1	LipopolysaccharidesIBA 10/2014
1	Thymic Stromal LymphopoietinIBA 10/2014
1	Histamine (Histamine Dihydrochloride)FDA Link 10/2014
1	Methanol (Carbinol)IBA 08/2014
1	HexanesIBA 08/2014
1	Biomarkers (Surrogate Marker)IBA 10/2011
1	CalciumIBA 10/2011
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 12/2009
1	Epinephrine (Adrenaline)FDA LinkGeneric 12/2009
1	Morphine (MS Contin)FDA LinkGeneric 12/2009
1	Opiate AlkaloidsIBA 12/2009
1	Lipoprotein(a)IBA 12/2007
1	Dipeptidyl-Peptidase IV InhibitorsIBA 08/2005
1	VildagliptinIBA 08/2005
1	Glucagon-Like Peptide 1 (GLP 1)IBA 08/2005
1	MetalsIBA 04/2005
1	DNA (Deoxyribonucleic Acid)IBA 01/2005
1	ProlactinIBA 11/2001
1	Nalidixic Acid FDA Link 03/2001
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2001
1	Ampicillin (Omnipen)FDA LinkGeneric 03/2001
1	Chloramphenicol (Chloromycetin)FDA Link 03/2001
1	Sumatriptan (Imigran)FDA LinkGeneric 03/2001

Therapy/Procedure

3	Therapeutics 05/2018 - 11/2014
1	Injections 01/2022
1	Patient Transfer (Patient Dumping) 01/2021
1	Lasers (Laser) 04/2018
1	Semiconductor Lasers 04/2018
1	Drug Therapy (Chemotherapy) 04/2016
1	Organ Transplantation 08/2010
1	Transplantation 08/2010
1	Analgesia 12/2009
1	Ileostomy 12/2009
1	Central Venous Catheters 12/2007
1	Catheters 09/2005
1	Glycemic Control 08/2005
1	Parenteral Nutrition 06/2003